Grant Glues Together Research Experts To Tackle Incurable Diseases (The Wertheim UF Scripps Institute)
UF researcher Thomas Kodadek’s team has won a prestigious international grant to collaborate with Merck KGaA on developing “molecular glue degraders,” a novel technology that harnesses the body’s recycling system to treat previously undruggable diseases like aggressive cancers and brain disorders.
Myosin Therapeutics Awarded $4.5 Million NCI Bridge Grant to Advance Phase I Trial of MT-125 in Glioblastoma (PR Newswire)
UF startup Myosin Therapeutics announced it has been awarded a $4.5M Phase IIB Bridge Award from the National Cancer Institute’s (NCI) Small Business Innovation Research (SBIR) program.